ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ULVR Unilever Plc

4,133.00
51.00 (1.25%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Unilever Plc LSE:ULVR London Ordinary Share GB00B10RZP78 ORD 3 1/9P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  51.00 1.25% 4,133.00 4,137.00 4,139.00 4,146.00 4,097.00 4,100.00 4,574,072 16:35:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Perfume,cosmetic,toilet Prep 59.6B 6.49B 2.5958 15.94 103.38B
Unilever Plc is listed in the Perfume,cosmetic,toilet Prep sector of the London Stock Exchange with ticker ULVR. The last closing price for Unilever was 4,082p. Over the last year, Unilever shares have traded in a share price range of 3,680.50p to 4,483.00p.

Unilever currently has 2,499,017,983 shares in issue. The market capitalisation of Unilever is £103.38 billion. Unilever has a price to earnings ratio (PE ratio) of 15.94.

Unilever Share Discussion Threads

Showing 1851 to 1873 of 3100 messages
Chat Pages: Latest  76  75  74  73  72  71  70  69  68  67  66  65  Older
DateSubjectAuthorDiscuss
17/1/2022
10:44
Jope has just signed his own death warrant, shareholders will never approve
this and his tenure now looks toast.

Bought a very small amount.

Pushed down further at the US open?.

essentialinvestor
17/1/2022
10:38
there has been talk of pe interest in unilever. maybe the ceo has rushed into doing something to avoid a takeover attempt. it seems that when it comes to his own job he is quite proactive. other than a takeover or change at the top, its hard to see the shares moving markedly higher.
roguetraderuk
17/1/2022
10:27
BARCLAYS CUTS UNILEVER PRICE TARGET TO 4,600 (4,800) PENCE - 'OVERWEIGHT'
philanderer
17/1/2022
10:26
This would have been a blue day if not for the buying of GSK unit
nick100
17/1/2022
10:23
RKT responding well this morning.
philanderer
17/1/2022
10:22
Market will not allow the deal is what the share price is indicating.

Beginning of the end for the CEO at a guess.

essentialinvestor
17/1/2022
10:17
They should respond immediately by withdrawing.
pander45
17/1/2022
10:16
How long will it take unilever board to see that the market does not like this deal by over paying.
nick100
17/1/2022
10:15
How to destroy your company, chapter 1. Eyes greedier than belly.
pander45
17/1/2022
10:09
Market usually loves this sort of deal making, so for the ULVR share price to react so negatively tells you all you need to know that this is a hare-brained deal.

To ram this through, serious debt would need to be taken on, the dividend would probably need to be cut for awhile, there'd also likely be some disposals (lots of value lost to the investment banks and government). A lot of pain would have to be taken to buy an asset that isn't cheap to acquire, will be low growth and has questionable synergy value.

I think in the longer-term, there's a very real prospect that Unilever itself may become a target. It's performing so poorly under the current weak management, is valued well below peers in the US and has already seen a bid from Kraft/Buffett rebuffed. Given how badly the company has performed the last bid I think Unilever is in a much weaker position to knock back any new bids.

Needless to say, as a shareholder I am really annoyed by this management team. Terry Smith really nailed it in his comments last week. It's time for shareholders to vote them out during the next AGM.

tabhair
17/1/2022
10:00
Falling knife. Drip feed purchases if you're keen to buy. Personally, I'm watching from the sidelines and can't see any rush to get involved.
25guilderbag
17/1/2022
09:48
Terry Smith timing on his article superb, I would imagine a lot of happy investors sold at higher level, saving around 6% of their investment capital.
montyhedge
17/1/2022
09:46
Terry Smith was right, these guys have totally lost their marbles. They've got enough brands and enough global coverage, if they focus on organic growth and margin expansion they will deliver for shareholders. I guess there's no fun in that.
squeamish1
17/1/2022
09:45
chart looks ugly. take a look at the 10 year chart and look at the rolling top since 2017. if the chart was the other way up, longs would be rubbing their hands in glee. but its not and just on pure techs, the target would be low 20's. thats a lot of value destruction that needs to happen but i think that might be avoided with a bid before it got that low. at present someone needs to offer 50 quid for the board to accept, but down there 46 quid might be accepted if the shares are in the low 30's. to put things into context on how badly the mkt views this action by unilever is that the shares are almost at the covid lows, a point where the world seemed to be ending.
roguetraderuk
17/1/2022
09:37
I think you mean reversion steve3etc but revulsion will do nicely.
keyno
17/1/2022
09:31
This is proving to be an expensive day

:(

marksp2011
17/1/2022
09:27
The combined value of gsk/Ulvr fallen on that news. Can’t imagine this deal will go through
big7ime
17/1/2022
09:20
Another one here who thinks it's mad to gear up £50/60Bn. FWIW I have bought a maiden Unilever holding to supplement a larger holding held in various ITs. £36.77 seems to take out Covid low and 3 year low so revulsion probably hereabouts? To think Unilever turned away £50 a few years ago. Get that Jope on the phone.
steve3sandal
17/1/2022
09:17
My GSK Holding is over 2x ULVR so not unduly concerned about news. Main concern for ULVR is to not get into a bidding war and overpay particulary if their paper gets any weaker. $50 billion is about right. I guess GSK holding out for cash in full. A lot of debt for ULVR to take on at these uncertain times so cash call would be on the cards.
rogerrail
17/1/2022
09:14
GlaxoSmithKline shares were up 5.2% early Monday, while Unilever shares were down 5.8%.

Analysts at Bernstein cut Unilever shares to Underperform from Market-Perform

(Alliance News)

philanderer
17/1/2022
09:09
I see a private equity offer soon. All imho.
pander45
17/1/2022
09:06
If I were gsk I wouldn't be accepting any ULVR paper with this idiot in charge
spoole5
17/1/2022
08:58
This is becoming a target now.
pander45
Chat Pages: Latest  76  75  74  73  72  71  70  69  68  67  66  65  Older

Your Recent History

Delayed Upgrade Clock